Medicare Enrolled
Christopher Byrne, PA
Physician Assistant · Fresh Meadows, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Byrne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Byrne?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Byrne
Christopher Byrne is a physician assistant in Fresh Meadows, NY, with 21 years of NPI registration. Based on federal Medicare data, Byrne performed 1,818 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Byrne received a total of $25,367 from 39 pharmaceutical and/or device companies across 937 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Byrne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 4% volume in NY
$25,367 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,818
Medicare services
Top 4% in NY for physician assistant
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
392 | $5 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
263 | $65 | $213 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
214 | $79 | $277 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
173 | $40 | $135 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
142 | $64 | $248 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
126 | $30 | $163 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
84 | $1 | $2 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
61 | $48 | $174 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
50 | $39 | $123 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $69 | $268 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
46 | $37 | $139 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
44 | $99 | $310 |
| Injection into skin growths, more than 7 A procedure involving the injection of medication into more than seven skin growths. |
35 | $46 | $168 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
34 | $90 | $284 |
| Home visit, new patient, low complexity A home visit for a new patient involving a low level of medical decision making. The visit lasts at least 30 minutes when time is used to determine the level of service. |
28 | $56 | $177 |
| Home visit, established patient, low complexity A physician visits an existing patient at their residence to provide care involving a low level of medical decision making. The visit lasts at least 30 minutes. |
25 | $60 | $175 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
21 | $49 | $172 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $96 | $300 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
14 | $121 | $413 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.9% high complexity
19.6% medium
78.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,367
Total received (2021-2024)
Avg $6,342/year across 4 years
Top 1% in NY for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
937
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,929
2023
$9,026
2022
$6,429
2021
$5,982
Payments by company (2024)
ABBVIE INC.
$654
Arcutis Biotherapeutics, Inc.
$624
Janssen Biotech, Inc.
$522
Novartis Pharmaceuticals Corporation
$436
E.R. Squibb & Sons, L.L.C.
$388
Lilly USA, LLC
$235
LEO Pharma Inc.
$232
Dermavant Sciences, Inc.
$231
UCB, Inc.
$152
SUN PHARMACEUTICAL INDUSTRIES INC.
$80
GENZYME CORPORATION
$71
Incyte Corporation
$65
PFIZER INC.
$60
Amgen Inc.
$54
Galderma Laboratories, L.P.
$36
STRATA Skin Sciences, Inc.
$28
Ortho Dermatologics, a division of Bausch Health US, LLC
$23
Regeneron Healthcare Solutions, Inc.
$22
Paratek Pharmaceuticals, Inc.
$18
Top 3 companies account for 45.8% of 2024 payments
All-time payments by company (2021-2024) ›
Medimetriks Pharmaceuticals, Inc.
$5,675
Incyte Corporation
$2,920
Janssen Biotech, Inc.
$2,666
ABBVIE INC.
$1,856
Novartis Pharmaceuticals Corporation
$1,648
Lilly USA, LLC
$1,310
ANI Pharmaceuticals, Inc.
$1,250
E.R. Squibb & Sons, L.L.C.
$1,169
LEO Pharma Inc.
$913
Almirall LLC
$757
Arcutis Biotherapeutics, Inc.
$718
UCB, Inc.
$564
PFIZER INC.
$448
SUN PHARMACEUTICAL INDUSTRIES INC.
$441
Amgen Inc.
$436
AbbVie Inc.
$376
GENZYME CORPORATION
$340
Galderma Laboratories, L.P.
$294
Dermavant Sciences, Inc.
$255
Verrica Pharmaceuticals Inc.
$250
Regeneron Healthcare Solutions, Inc.
$227
VYNE Pharmaceuticals Inc.
$153
EPI Health, LLC
$116
Sun Pharmaceutical Industries Inc.
$73
MAYNE PHARMA COMMERCIAL LLC
$69
Merz North America, Inc.
$62
DERMIRA, INC.
$57
Ortho Dermatologics, a division of Bausch Health US, LLC
$47
Mission Pharmacal Company
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$39
Journey Medical Corporation
$38
STRATA Skin Sciences, Inc.
$28
Biofrontera Inc.
$22
Fresenius Kabi USA, LLC
$20
Helsinn Therapeutics (U.S.), Inc.
$20
Sebela Pharmaceuticals Inc.
$18
Paratek Pharmaceuticals, Inc.
$18
MAYNE PHARMA INC.
$14
Allergan, Inc.
$14
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Avar · BOTOX · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · DUPIXENT · EBGLYSS · ENSTILAR · EUCRISA · HUMIRA · ILUMYA · Ilumya · Klisyri · LIBTAYO · NAFTIN · NUZYRA · Neo-Synalar · OLUMIANT · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RINVOQ · SKYRIZI · SPEVIGO · Seysara · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · VALCHLOR · VTAMA · Veregen · Winlevi · XTRAC · Xeomin · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Physician assistants in nearby ZIP areas
9,556
County median income
$84,961
Nearest hospital to ZIP centroid (approximate)
NEW YORK-PRESBYTERIAN/QUEENS
1.6 mi
1.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Byrne is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Byrne experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Byrne performed 392 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Byrne receive payments from pharmaceutical companies?
Yes. Byrne received a total of $25,367 from 39 companies across 937 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Byrne's costs compare to other physician assistants in Fresh Meadows?
Byrne's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Byrne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Physician Assistants in Fresh Meadows
Browse physician assistants in Fresh Meadows ranked by procedure volume and transparency data.
Highest volume
Top Physician Assistants in NY
Physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physician Assistants in NY
Which NY physician assistants receive the most from drug and device companies.
By company
Medimetriks Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Medimetriks Pharmaceuticals, Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology